Endocrinology of Pregnancy Practice Questions

Q: What is the threshold of hemoglobin A1c for the diagnosis of diabetes in pregnancy?

6.50%. **Explanation:** The diagnosis of diabetes in pregnancy is categorized into two types: **Overt (Pre-gestational) Diabetes** and **Gestational Diabetes Mellitus (GDM)**. According to the WHO and ADA guidelines, the threshold for diagnosing overt diabetes during the first prenatal visit is an **HbA1c ≥ 6.5%**. 1. **Why 6.5% is correct:** This value is the standardized diagnostic cutoff for diabetes in the non-pregnant population. When a woman presents in early pregnancy with an HbA1c of 6.5% or higher, it indicates that she likely had undiagnosed pre-existing (overt) diabetes prior to conception, rather than GDM, which typically develops in the second half of pregnancy due to placental hormones. 2. **Analysis of Incorrect Options:** * **6% (Option A):** While an HbA1c between 5.7% and 6.4% is considered "prediabetes" in non-pregnant individuals, it is not the diagnostic threshold for diabetes. * **7% (Option C):** This is often the therapeutic *target* for glycemic control in non-pregnant diabetics, but it is too high for a diagnostic threshold. * **7.5% (Option D):** This value has no specific diagnostic significance in the context of pregnancy screening. **High-Yield Clinical Pearls for NEET-PG:** * **DIPSI Guidelines:** In India, the "single-step" 75g Oral Glucose Tolerance Test (OGTT) is preferred. A 2-hour plasma glucose **≥ 140 mg/dL** diagnoses GDM, regardless of the fasting status. * **HbA1c Limitations:** HbA1c is less reliable in the 2nd and 3rd trimesters due to increased red cell turnover. It is primarily used in the **1st trimester** to rule out overt diabetes. * **Fasting Plasma Glucose (FPG):** An FPG **≥ 126 mg/dL** at the first visit also diagnostic of overt diabetes.

Q: Maximum cardiac output is seen during which phase of pregnancy?

Immediate postpartum period. **Explanation:** The **immediate postpartum period** (specifically the first 10–15 minutes after delivery) marks the peak of cardiac output (CO) during the entire pregnancy cycle. This occurs due to two primary mechanisms: 1. **Autotransfusion:** The contraction of the uterus after delivery forces approximately 300–500 mL of blood back into the maternal systemic circulation. 2. **Relief of Caval Compression:** The delivery of the fetus removes the weight of the gravid uterus from the inferior vena cava, leading to a sudden increase in venous return (preload) to the heart. These factors result in a CO increase of nearly **60–80%** above pre-labor values. **Analysis of Incorrect Options:** * **First Trimester:** CO begins to rise early (around 5 weeks) due to increased stroke volume and heart rate, but it is far from its peak. * **Second Trimester:** CO continues to rise, reaching its highest **ante-partum** levels (about 30–50% above baseline) by 28–32 weeks. It then plateaus until labor. * **Labor:** CO increases progressively during labor (approx. 15% in the first stage and 50% in the second stage) due to pain, anxiety, and uterine contractions, but it does not reach the absolute peak seen immediately after birth. **High-Yield Clinical Pearls for NEET-PG:** * **Maximum Risk of Heart Failure:** Because the immediate postpartum period sees the highest CO, this is the most dangerous time for women with pre-existing heart disease (e.g., Mitral Stenosis). * **Hemodynamic Trend:** CO returns to pre-labor values within 1 hour and to pre-pregnancy levels by 6–12 weeks postpartum. * **Blood Volume:** Peaks at 32–34 weeks of gestation (approx. 50% increase). * **Blood Pressure:** Diastolic BP reaches its nadir (lowest point) in the second trimester.

Q: All of the following are biological tests for pregnancy, EXCEPT:

Inhibition latex slide test. ### Explanation The diagnosis of pregnancy has evolved from historical animal-based assays to modern immunological techniques. To answer this question, one must distinguish between **Biological (Bioassays)** and **Immunological** tests. **Why "Inhibition latex slide test" is the correct answer:** The Inhibition latex slide test is an **immunological test**, not a biological one. It is based on the principle of **agglutination inhibition**. In this test, the patient’s urine (containing hCG) is mixed with anti-hCG antibodies. If hCG is present, it neutralizes the antibodies. When latex particles coated with hCG are subsequently added, no agglutination occurs (a positive result). Because it relies on antigen-antibody reactions rather than a physiological response in a living organism, it is classified as an immunological assay. **Analysis of Incorrect Options (Biological Tests):** Biological tests (Bioassays) involve injecting a patient's urine/serum into animals and observing physiological changes in their reproductive organs due to the presence of hCG: * **Gall-Mainini test:** Uses male frogs/toads. A positive result is the presence of spermatozoa in the frog's cloaca after injection. * **Friedman test:** Uses female rabbits. A positive result is the presence of corpora lutea or hemorrhagic follicles in the ovaries. * **Hogben test:** Uses the female Xenopus laevis (toad). A positive result is ovulation (egg-laying) within 12–24 hours. **NEET-PG High-Yield Pearls:** * **Aschheim-Zondek (A-Z) test:** The first biological test, which used immature female mice. * **Gold Standard:** Today, the most sensitive and specific test is the **Immunometric (Sandwich) ELISA** for the β-subunit of hCG. * **hCG Levels:** hCG is secreted by syncytiotrophoblasts. It is detectable in maternal serum 8–9 days after fertilization and peaks at **10 weeks** (approx. 100,000 mIU/mL).

Q: What is the drug of choice for hypertension in eclampsia?

Magnesium Sulphate. **Explanation:** The correct answer is **Magnesium Sulphate (MgSO₄)**. In the context of eclampsia, the primary goal is to control seizures and prevent recurrence. While MgSO₄ is technically an anticonvulsant and not a direct antihypertensive, it is considered the **drug of choice for the management of eclampsia** because it addresses the underlying pathophysiology (cerebral vasospasm) and significantly reduces maternal mortality compared to other agents. **Why other options are incorrect:** * **Labetalol:** This is the first-line antihypertensive for managing **severe hypertension** (BP ≥160/110 mmHg) in pregnancy and pre-eclampsia. However, it does not prevent or treat the seizures of eclampsia. * **Hydralazine:** Previously the gold standard for hypertensive emergencies in pregnancy, it is now a second-line option due to side effects like tachycardia and headaches. * **Nifedipine:** A calcium channel blocker used for oral management of hypertension in pregnancy, but it is not the definitive treatment for the eclamptic state itself. **High-Yield Clinical Pearls for NEET-PG:** * **Pritchard Regimen:** The standard IM loading dose is 4g IV (20%) + 10g IM (5g in each buttock), followed by 5g IM every 4 hours. * **Therapeutic Range:** 4–7 mEq/L. * **Toxicity Monitoring:** Always check **Patellar reflex** (first sign of toxicity to disappear), **Respiratory rate** (>12/min), and **Urine output** (>30ml/hr). * **Antidote:** Calcium Gluconate (10ml of 10% solution IV over 10 minutes). * **Note:** If the question specifically asks for the drug of choice to *lower blood pressure* in a hypertensive crisis, Labetalol is the answer; however, for the *overall management of eclampsia*, MgSO₄ is the priority.

Q: Which of the following is a cause of female pseudohermaphroditism?

21-alpha hydroxylase deficiency. **Explanation:** **Female Pseudohermaphroditism** (now termed 46,XX Disorders of Sex Development) occurs when a genotypically female individual (46,XX) possesses ovaries but exhibits ambiguous or virilized external genitalia due to excessive androgen exposure in utero. **Why Option B is Correct:** **21-alpha hydroxylase deficiency** is the most common cause of **Congenital Adrenal Hyperplasia (CAH)**. In this condition, a block in the cortisol synthesis pathway leads to an accumulation of precursors (like 17-OH progesterone), which are shunted into the androgen pathway. The resulting high levels of testosterone and androstenedione cause virilization of the female fetus (clitoromegaly, labial fusion), making it the classic cause of female pseudohermaphroditism. **Why Other Options are Incorrect:** * **Option A (17-alpha hydroxylase deficiency):** This block prevents the production of both sex steroids and cortisol. In a 46,XX individual, it leads to a lack of pubertal development (primary amenorrhea) rather than virilization. In a 46,XY individual, it causes **male pseudohermaphroditism** (undervirilization). * **Option C (Mixed Gonadal Dysgenesis):** This is a chromosomal disorder (typically 45,X/46,XY mosaicism). It is characterized by a streak gonad on one side and a testis on the other. It is not classified as female pseudohermaphroditism because the gonads are abnormal/dysgenetic. **High-Yield NEET-PG Pearls:** * **Most common cause of CAH:** 21-alpha hydroxylase deficiency (90-95% of cases). * **Biochemical marker:** Elevated **17-hydroxyprogesterone (17-OHP)**. * **Clinical presentation:** Salt-wasting (hypotension, hyponatremia, hyperkalemia) occurs in the "salt-losing" form due to aldosterone deficiency. * **Maternal cause:** Maternal ingestion of androgens or androgen-secreting tumors (Luteoma of pregnancy) can also cause female pseudohermaphroditism.

Q: What is the safe drug for antihypertensive crisis during pregnancy?

Hydralazine. **Explanation:** The management of hypertension in pregnancy is categorized into chronic management and the management of an **acute hypertensive crisis** (defined as BP ≥160/110 mmHg). **Why Hydralazine is correct:** Hydralazine is a potent direct-acting peripheral vasodilator. It is considered a first-line agent for **hypertensive emergencies** in pregnancy because of its rapid onset of action (5–20 minutes) when administered intravenously. It effectively reduces systemic vascular resistance, ensuring rapid stabilization of blood pressure to prevent maternal intracranial hemorrhage. **Analysis of Incorrect Options:** * **Enalapril (Option A):** ACE inhibitors are strictly **contraindicated** in pregnancy (Category X). They are teratogenic and can cause fetal renal dysgenesis, oligohydramnios, and skull hypoplasia. * **Methyldopa (Option C):** While Methyldopa is the **drug of choice for chronic hypertension** in pregnancy, it is unsuitable for a crisis. It has a slow onset of action (4–6 hours) and works via a central mechanism, making it ineffective for immediate BP reduction. * **Option D:** Incorrect because Methyldopa cannot be used for an acute crisis. **High-Yield Clinical Pearls for NEET-PG:** 1. **First-line drugs for Hypertensive Crisis:** IV Labetalol (most common/preferred), IV Hydralazine, and Oral Nifedipine (rapid release). 2. **Drug of Choice (DOC) for Chronic Hypertension:** Methyldopa (safest long-term profile). 3. **DOC for Eclampsia/Preeclampsia Seizures:** Magnesium Sulfate ($MgSO_4$). 4. **Avoid in Pregnancy:** ACE inhibitors, ARBs, Sodium Nitroprusside (risk of fetal cyanide poisoning), and Diuretics (may compromise placental perfusion).

Q: At what gestational age can the fetal ovary produce estrogen?

8 weeks. **Explanation:** The development of the fetal endocrine system is a high-yield topic for NEET-PG. The correct answer is **8 weeks**, as this marks the functional onset of steroidogenesis in the fetal ovary. **1. Why 8 weeks is correct:** By the **8th week of gestation**, the fetal ovary begins the synthesis of estrogen. Unlike the fetal testes, which produce testosterone and Anti-Müllerian Hormone (AMH) to drive male differentiation, the fetal ovary does not require its own hormones for female phenotypic development. However, the enzymatic machinery required to convert precursors into estrogens becomes active at this stage. **2. Analysis of Incorrect Options:** * **6 weeks (Option A):** At this stage, the gonads are still "indifferent." Morphological and functional differentiation into ovaries or testes has not yet progressed enough to produce steroid hormones. * **10 weeks (Option B) & 12 weeks (Option D):** While estrogen production continues and increases during these weeks, the *initial* capability is established earlier at the 8-week mark. By 12 weeks, the placenta takes over as the primary source of systemic estrogen (estriol) for the pregnancy. **3. High-Yield Clinical Pearls for NEET-PG:** * **Source of Estrogen:** In pregnancy, **Estriol (E3)** is the dominant estrogen. Its synthesis requires a functional "Fetoplacental Unit" (Fetal adrenals provide DHEAS $\rightarrow$ Fetal liver performs 16-hydroxylation $\rightarrow$ Placenta performs aromatization). * **Testosterone Production:** Fetal testes begin producing testosterone slightly earlier, around **7–8 weeks**, peaking at 12–14 weeks. * **Ovarian Development:** Germ cell mitosis in the fetal ovary peaks at **20 weeks**, reaching approximately 7 million oogonia. * **Key Marker:** Serum estriol levels are used in the **Triple/Quadruple marker screen**; low levels may indicate Down Syndrome or Edwards Syndrome.

Q: Doubling of Beta HCG levels is typically seen in approximately what time frame?

48 hours. **Explanation:** The correct answer is **48 hours**. **1. Why 48 hours is correct:** Human Chorionic Gonadotropin (β-hCG) is produced by the syncytiotrophoblast of the developing placenta. In a healthy, viable intrauterine pregnancy (IUP), β-hCG levels rise exponentially during the first trimester. The "doubling time" is a clinical benchmark used to assess pregnancy viability. In approximately 85% of normal early pregnancies, the β-hCG level increases by at least 66% every 48 hours, with the average doubling time being roughly 1.5 to 2 days. **2. Why the other options are incorrect:** * **24 hours:** While β-hCG rises rapidly, a 100% increase in just 24 hours is faster than the physiological norm and is rarely seen. * **72 to 96 hours:** While the doubling time slows down as pregnancy progresses (specifically after reaching 6,000–10,000 mIU/mL), these timeframes are considered too slow for the initial stages of a healthy IUP. A rise of less than 35% in 48 hours is highly suggestive of an ectopic pregnancy or a non-viable intrauterine gestation (impending miscarriage). **3. High-Yield Clinical Pearls for NEET-PG:** * **Peak Levels:** β-hCG levels peak at **8–10 weeks** of gestation (reaching ~100,000 mIU/mL) and then decline to a lower plateau for the remainder of the pregnancy. * **Discriminatory Zone:** This is the level of β-hCG (usually **1,500–2,000 mIU/mL**) at which a gestational sac should be visible on Transvaginal Sonography (TVS). * **Abnormal Patterns:** * **Slow rise/Plateau:** Suggests Ectopic Pregnancy. * **Rapidly falling:** Suggests Abortion. * **Pathologically high:** Suggests Molar pregnancy, Multiple gestations, or Choriocarcinoma.

Question 1

Which of the following statements regarding early pregnancy events is true?

Accepted Answer

Fertilization of the ovum commonly occurs in the ampulla of the fallopian tube.

Answer

The placenta begins to form during the morula stage.

Answer

Implantation of the blastocyst typically occurs around the 10th day after fertilization.

Answer

During the initial weeks of pregnancy, the survival of the corpus luteum is primarily dependent on LH.

Question 2

What is the threshold of hemoglobin A1c for the diagnosis of diabetes in pregnancy?

Accepted Answer

6.50%

Answer

6%

Answer

7%

Answer

7.50%

Question 3

Maximum cardiac output is seen during which phase of pregnancy?

Accepted Answer

Immediate postpartum period

Answer

First trimester

Answer

Second trimester

Answer

Labor

Question 4

All of the following are biological tests for pregnancy, EXCEPT:

Accepted Answer

Inhibition latex slide test

Answer

Gall - Mainini test

Answer

Friedman test

Answer

Hogben test

Question 5

What is the drug of choice for hypertension in eclampsia?

Accepted Answer

Magnesium Sulphate

Answer

Nifedipine

Answer

Hydralazine

Answer

Labetalol

Question 6

Which of the following is a cause of female pseudohermaphroditism?

Accepted Answer

21-alpha hydroxylase deficiency

Answer

17-alpha hydroxylase deficiency

Answer

Mixed gonadal dysgenesis

Answer

All of the above

Question 7

What is the safe drug for antihypertensive crisis during pregnancy?

Accepted Answer

Hydralazine

Answer

Enalapril

Answer

Methyldopa

Answer

Both Hydralazine and Methyldopa

Question 8

At what gestational age can the fetal ovary produce estrogen?

Accepted Answer

8 weeks

Answer

6 weeks

Answer

10 weeks

Answer

12 weeks

Question 9

Which of the following is considered the gold standard for demonstrating human chorionic gonadotropin (hCG)?

Accepted Answer

Radioimmunoassay (RIA)

Answer

Latex agglutination

Answer

Immunofluorescence

Answer

Enzyme-linked immunosorbent assay (ELISA)

Question 10

Doubling of Beta HCG levels is typically seen in approximately what time frame?

Accepted Answer

48 hours

Answer

24 hours

Answer

72 hours

Answer

96 hours

Endocrinology of Pregnancy — MCQs

Endocrinology of Pregnancy — MCQs

On this page

Practice by Chapter

Want unlimited practice?